Myeloid Therapeutics logo

Myeloid Therapeutics

Cambridge, MA

Myeloid Therapeutics is an immunology company focused on combining biology insights with cutting-edge technologies to harness myeloid cells and eradicate cancer and other diseases.

myeloidtx.com

Company Details

Founded

2019

Employees

Between 20 - 100 employees

Raised

Unknown

Headquarters Location

Cambridge, MA

Public

No

Acquired

No

CEO

Daniel GettsDaniel Getts

Founders

Siddhartha Mukherjee
Siddhartha Mukherjee
Yuxiao Wang
Yuxiao Wang
Thomas Cahill
Thomas Cahill
Ronald Vale
Ronald Vale
Daniel Getts
Daniel Getts

Company Collections

These are collections Myeloid Therapeutics is a part of. Click on the collection name to view similar companies.

Myeloid Therapeutics' Tech Stack

Myeloid Therapeutics' Investors

Myeloid Therapeutics Headquarters Location

300 Technology Square suite 203, Cambridge, MA 02139

Total Amount Raised:

Myeloid Therapeutics' Investors

Myeloid Therapeutics Funding Rounds

  • Series A

    $73,000,000

    Series A Investors

    Hatteras Venture Partners
    Newpath Partners
    Moore Strategic Ventures
    Alexandria Venture Investments
    Arch Venture Partners
    8VC
  • Grant

    96,000,000 AUD

    Grant Investors

    NSW Government
  • Series A

    $50,000,000

    Series A Investors

    Newpath Partners
    8VC
    Alexandria Venture Investments
    Hatteras Venture Partners
Funding info provided by Diffbot.

Myeloid Therapeutics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Myeloid Therapeutics.

Recent reviews